✦ LIBER ✦

P.2.090 The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

✍ Scribed by G. Everson; K.C. Lasseter; K.E. Anderson; N.G. Egger; D.E. Goeger; L.A. Bauer; J. Lill; K.D. Wilner; A. Johnson; R. Anziano

Book ID: 118600012
Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 152 KB
Volume: 7
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(97)88724-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P.2.068 The pharmacokinetics of ziprasid

P.2.068 The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

✍ F. Aweeka; D. Jayesekara; M. Horton; S. Swan; L. Lambrecht; K.D. Wilner; J. Sher 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 285 KB

Pharmacokinetics and safety of tamsulosi

Pharmacokinetics and safety of tamsulosin in subjects with normal and impaired renal or hepatic function

✍ Yasushi Miyazawa; Robert A. Blum; Jerome J. Schentag; Hidetaka Kamimura; Hiroshi 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 892 KB

Pharmacokinetics of naproxen in subjects

Pharmacokinetics of naproxen in subjects with normal and impaired renal function

✍ M. Anttila; M. Haataja; A. Kasanen 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 473 KB

Pharmacokinetics of Cefoperazone in Pati

Pharmacokinetics of Cefoperazone in Patients with Normal and Impaired Hepatic and Renal Function

✍ Greenfield, R. A.; Gerber, A. U.; Craig, W. A. 📂 Article 📅 1983 🏛 University of Chicago Press 🌐 English ⚖ 879 KB

Steady-state pharmacokinetics of nefazod

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

✍ R. H. Barbhaiya; M. E. Brady; U. A. Shukla; D. S. Greene 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 604 KB

The steady-state pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were compared in subjects with normal and impaired renal function. Patients: The Study was of parallel group design which included 7 subjects with normal (NOR) ren

Pharmacokinetics and safety of candesart

Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function

✍ J. F. W. Hoogkamer; C. H. Kleinbloesem; M. Ouwerkerk; A. Högemann; A. Nokhodian; 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 296 KB